surgical minimally invasive News
-
New View Surgical, Inc. Closes Series A Round of Financing
New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery, announced that it closed its Series A Financing Round at $2.5 million. The financing was over-subscribed due to investor demand. New View Surgical will deploy the financing to complete the development of its VisionPort™ System, expand the ...
-
New View Surgical, Inc. Recognized as ‘Most Valued Company’ at virtual Keiretsu Forum Investor Capital Expo
New View Surgical, Inc. an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery, was recognized as one of the top three ‘Most Valued Company’ at the Keiretsu Forum Investor Capital Expo that is showcasing 36 late-stage growth companies seeking funding. Nearly 50 angel groups, investors from 100+ Family Offices, corporate ...
-
Neurent Medical`s RF-based Minimally Invasive Rhinitis Therapy Earns Acclaim from Frost & Sullivan
Neurent Medical's rhinitis device delivers radio frequency energy in a focused and controllable zone of effect, causing minimal collateral damage to surrounding tissues LONDON, Nov. 13, 2018 /CNW/ -- Based on its recent analysis of the European rhinitis therapy market, Frost & Sullivan recognises Neurent Medical with the 2018 European New Product Innovation Award for developing a ...
-
New Study Gets to the Root of Fixing Pediatric Flatfeet
GraMedica is pleased to announce that the research team of Dr. Philip J. Bresnahan and Dr. Mario A. Juanto have published a new study this month focused on the misinformation surrounding the treatment of a common deformity known as pediatric flatfeet. Pediatric flatfeet are caused by the partial dislocation of the ankle bone on the heel bone. Historically, many medical professionals have not ...
By GraMedica
-
New View Surgical, Inc. Announces FDA Clearance of its VisionPort™ System for Minimally Invasive Surgery
New View Surgical, Inc., a medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for its VisionPort™ System. The VisionPort™ imaging and access system simplifies laparoscopic procedures for hospitals and provides surgeon-controlled ...
-
Cardiac Dimensions Included in the New 2021 ESC Guidelines for Heart Failure Management
Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the mention of their Carillon Mitral Contour System in the 2021 European Society of Cardiology (ESC) Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. In addition, the Carillon Mitral ...
-
BioPoly Oversubscribes $2M Private Equity Offering
FORT WAYNE, IN – BioPoly, LLC announced today that it has fully subscribed its latest round of private equity financing of $2M. The financing round also includes oversubscription funding of $890k. BioPoly has now raised over $20M through its initial grants ($3.27M) and private equity offerings. The funds received from the most recent private offering will be used to bring products to the ...
By BioPoly, LLC
-
Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors
DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced the appointment of two new independent members to the company’s board of directors, Jeffrey Dunn and Eric Major. These appointments bring Mainstay’s total board membership to seven. “We are pleased to welcome these two transformational business leaders as new independent directors on the ...
-
Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation
Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Therapeutic Goods Administration (TGA) has approved its Carillon Mitral Contour System®. The Carillon System is a right heart transcatheter mitral valve repair (TMVr) device designed to treat the ...
-
HistoSonics Appoints Dr. Joe Amaral to Vice President of Medical Affairs
HistoSonics announced today the appointment of Joe Amaral, MD, to the newly created position of Vice President of Medical Affairs, where he will oversee global clinical development initiatives for the company. Dr. Amaral brings with him more than 35 years of significant clinical and executive leadership in the healthcare space. Most recently, Dr. Amaral was Global Vice President of Surgical ...
By HistoSonics
-
BioPoly Granted US Patent for Its Implant Technology
FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its partial resurfacing implants which protects the innovative implant designs. The Company’s intellectual property portfolio also consists of patents that address its unique BioPoly® material. This most recent patent further adds to the Company’s IP portfolio, providing assurance that ...
By BioPoly, LLC
-
BioPoly Granted an International Patent for Its Implant Technology
FORT WAYNE, IN – BioPoly LLC has announced that the Company has further expanded its intellectual property portfolio. The Company was granted another international patent for its partial resurfacing implants which protects the innovative implant designs. In addition to patents that cover the design of its implants, several U.S. and international patents have also been granted that address ...
By BioPoly, LLC
-
World`s First Use of Lightpoint Medical`s Robotic Gamma Probe in Lung Surgery Performed in the U.S.
Lightpoint Medical today announced that Dr. Doug Adams, a specialist in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio) performed a first-in-the-world lung procedure with SENSEI, the company's new miniature robotic gamma probe. SENSEI is smaller than an AA battery and designed specifically for robotic and minimally-invasive surgery. The miniature size and ...
-
Lazurite™ Named One of the Industry’s Hottest Companies by World’s Largest MedTech Accelerator
MedTech Innovator, the world’s largest accelerator of medical technology companies, yesterday named Lazurite as one of the MedTech industry’s hottest 50 companies by selecting it to participate in Medtech Innovator’s flagship four-month Accelerator program featuring medical device, diagnostic, and digital health technologies from around the globe. As a 2022 Cohort member, ...
-
Could a Wireless Camera Improve Safety, Cost, & Efficiency in the OR?
Surgery has inherent risks, but wires and lights probably do not immediately come to mind as safety threats. Yet, in the OR, a large number of wires could contribute to falls and procedure delays, and high-heat lights could cause injuries. Lazurite Holdings LLC hopes to address these issues as well as promote efficiency with its inaugural and platform product, Arthrofree Wireless Camera System. ...
-
Mid Atlantic Bio Angels Invests in New View Surgical
Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in Boston-based New View Surgical., which has developed a proprietary surgical imaging system for laproscopic surgery. This is the eighth investment made by MABA since its founding. “Laproscopic and minimally invasive surgeries have become the norm, and it is important that physicians have the most updated ...
-
Flowonix Medical Partners with Miratech Medical for Distribution of Its Targeted Drug Delivery Products
Flowonix Medical and Miratech Medical today announced the acquisition of the U.S. distribution rights to Flowonix’s state-of-the-art targeted drug delivery system for the treatment of chronic pain and spasticity by Miratech Medical in a transaction that closed on May 11th. Miratech has long served as the exclusive agent for Flowonix products for certain markets, primarily in the Midwest. ...
-
Dr. James Lynch is the First US Private Practice Surgeon to Use Augmented Reality Spine Surgical Guidance at a Community Hospital
RENO, Nev., July 1, 2020 /PRNewswire/ — Spine Nevada Minimally Invasive Spine Institute announced that Dr. James Lynch, a board-certified and fellowship-trained neurological surgeon, was the first private practice surgeon in the United States to use the Augmedics xvision Spine System at a community hospital. xvision is the first Augmented Reality Guidance system to be used in surgery. It ...
By Augmedics
-
iSTAR Medical Expands Commercial Rollout with First MINIject Surgeries in Switzerland
The only commercially available MIGS device currently targeting the supraciliary space now available to patients and surgeons in Switzerland First implantations performed by Prof. Dr Kaweh Mansouri at Swiss Visio, Clinique de Montchoisi, Lausanne and Prof. Dr med. Jan Darius Unterlauft at Inselspital, Bern WAVRE, Belgium — 10 May 2022: iSTAR Medical, a medtech company delivering ...
-
TissueTech Grows Sales Force to Support Footprint Expansion
TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue allografts to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, announced today that they had completed a new round of hiring for their two commercial subsidiaries Bio-Tissue and Amniox Medical. The recently hired sales representatives and associate sales ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you